1. Home
  2. CABA vs JACK Comparison

CABA vs JACK Comparison

Compare CABA & JACK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cabaletta Bio Inc.

CABA

Cabaletta Bio Inc.

HOLD

Current Price

$1.42

Market Cap

339.1M

Sector

Health Care

ML Signal

HOLD

Logo Jack In The Box Inc.

JACK

Jack In The Box Inc.

SELL

Current Price

$12.21

Market Cap

326.6M

ML Signal

SELL

Company Overview

Basic Information
Metric
CABA
JACK
Founded
2017
1951
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
339.1M
326.6M
IPO Year
2019
1994

Fundamental Metrics

Financial Performance
Metric
CABA
JACK
Price
$1.42
$12.21
Analyst Decision
Buy
Hold
Analyst Count
10
16
Target Price
$13.25
★ $19.83
AVG Volume (30 Days)
★ 5.3M
478.4K
Earning Date
11-09-2026
11-18-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 10.26
N/A
EPS
N/A
★ 1.44
Revenue
N/A
★ $1,465,314,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$0.94
P/E Ratio
★ N/A
$8.79
Revenue Growth
★ N/A
N/A
52 Week Low
$1.51
$8.92
52 Week High
$4.23
$23.86

Technical Indicators

Market Signals
Indicator
CABA
JACK
Relative Strength Index (RSI) 20.85 39.80
Support Level N/A $11.92
Resistance Level $2.14 $14.02
Average True Range (ATR) 0.14 0.61
MACD -0.03 0.07
Stochastic Oscillator 4.74 29.91

Price Performance

Historical Comparison
CABA
JACK

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a late clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for autoimmune diseases. Its proprietary Cabaletta Approach to B cell Ablation (CABA) platform includes the CARTA approach, which uses chimeric antigen receptor T cells to eliminate B cells and potentially reset the immune system. The company develops cellular therapies including CAR T and CAAR T product candidates. Its candidate, rese-cel (resecabtagene autoleucel), a CD19-CAR T cell therapy, is being evaluated in Phase 1/2 trials for autoimmune diseases such as systemic lupus erythematosus, myositis, systemic sclerosis, generalized myasthenia gravis, and pemphigus vulgaris.

About JACK Jack In The Box Inc.

Jack In The Box Inc operates quick-service restaurants and fast-casual restaurants across various states in the United States of America. Its core business includes the Jack in the Box hamburger chain, known for a broad menu that features hamburgers, tacos, sandwiches, salads, and breakfast items. The company also operates the Del Taco brand, which offers a variety of both Mexican and American favorites such as burritos and fries. These foods are available with the option of customization as per customer requirements. The company also offers catering and delivery services to its customers. Jack in the Box and Del Taco restaurant brands are the two reportable operating segments, of which, Jack in the Box generates maximum revenue for the company.

Share on Social Networks: